

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.14565863 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.14565863 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.98313219 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.98313219 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.25075806 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.11811634 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11811634 |
| 8 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.07003625 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.95718839 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.95718839 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.95718839 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.95718839 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.95718839 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.95718839 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.79070802 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 4.62001186 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48953092 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46093528 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.32448886 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.28847248 |
| 21 | serine family amino acid biosynthetic process (GO:0009070) | 4.28155003 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.27060148 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 4.21441374 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19544545 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.17496189 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.16575901 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16526416 |
| 28 | cysteine metabolic process (GO:0006534) | 4.13725542 |
| 29 | L-serine metabolic process (GO:0006563) | 4.12965204 |
| 30 | keratinization (GO:0031424) | 4.11929108 |
| 31 | protein retention in ER lumen (GO:0006621) | 4.11560200 |
| 32 | lysine metabolic process (GO:0006553) | 4.11278358 |
| 33 | lysine catabolic process (GO:0006554) | 4.11278358 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 4.08041661 |
| 35 | positive T cell selection (GO:0043368) | 4.07288808 |
| 36 | thymic T cell selection (GO:0045061) | 4.02821824 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.01240470 |
| 38 | nucleobase catabolic process (GO:0046113) | 3.98562896 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.96611004 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 3.95979988 |
| 41 | T cell selection (GO:0045058) | 3.95298708 |
| 42 | glycine metabolic process (GO:0006544) | 3.94791707 |
| 43 | plasma lipoprotein particle assembly (GO:0034377) | 3.94496016 |
| 44 | response to muramyl dipeptide (GO:0032495) | 3.91137949 |
| 45 | mannose metabolic process (GO:0006013) | 3.89985236 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.86212401 |
| 47 | regulation of fibrinolysis (GO:0051917) | 3.85422842 |
| 48 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.83835492 |
| 49 | kynurenine metabolic process (GO:0070189) | 3.83259159 |
| 50 | regulation of receptor recycling (GO:0001919) | 3.77594276 |
| 51 | serine family amino acid metabolic process (GO:0009069) | 3.77158508 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.76401691 |
| 53 | response to peptidoglycan (GO:0032494) | 3.75658219 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 3.71689787 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.70889130 |
| 56 | glutamate metabolic process (GO:0006536) | 3.70399325 |
| 57 | bile acid biosynthetic process (GO:0006699) | 3.68800635 |
| 58 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.68418828 |
| 59 | phospholipid efflux (GO:0033700) | 3.66168836 |
| 60 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.65314245 |
| 61 | intestinal cholesterol absorption (GO:0030299) | 3.62942390 |
| 62 | ketone body metabolic process (GO:1902224) | 3.62037759 |
| 63 | cholesterol efflux (GO:0033344) | 3.60790032 |
| 64 | urea metabolic process (GO:0019627) | 3.58600383 |
| 65 | urea cycle (GO:0000050) | 3.58600383 |
| 66 | negative regulation of catenin import into nucleus (GO:0035414) | 3.57307393 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 3.56029823 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.54956180 |
| 69 | negative regulation of lipase activity (GO:0060192) | 3.54241577 |
| 70 | negative T cell selection (GO:0043383) | 3.53083010 |
| 71 | aromatic amino acid family metabolic process (GO:0009072) | 3.52379217 |
| 72 | cellular extravasation (GO:0045123) | 3.51205195 |
| 73 | leukocyte aggregation (GO:0070486) | 3.50341730 |
| 74 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.49565183 |
| 75 | protein-lipid complex assembly (GO:0065005) | 3.49005290 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 3.48567420 |
| 77 | tryptophan catabolic process (GO:0006569) | 3.48223383 |
| 78 | indole-containing compound catabolic process (GO:0042436) | 3.48223383 |
| 79 | indolalkylamine catabolic process (GO:0046218) | 3.48223383 |
| 80 | tyrosine metabolic process (GO:0006570) | 3.46501131 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.44515160 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.40291193 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.40291193 |
| 84 | positive regulation of histone deacetylation (GO:0031065) | 3.39812507 |
| 85 | tryptophan metabolic process (GO:0006568) | 3.37292239 |
| 86 | negative regulation of interleukin-12 production (GO:0032695) | 3.32468897 |
| 87 | nitrogen cycle metabolic process (GO:0071941) | 3.32342919 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 3.30757604 |
| 89 | NIK/NF-kappaB signaling (GO:0038061) | 3.30650229 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.30055346 |
| 91 | regulation of protein activation cascade (GO:2000257) | 3.28642227 |
| 92 | regulation of mast cell degranulation (GO:0043304) | 3.28442792 |
| 93 | bile acid metabolic process (GO:0008206) | 3.26832033 |
| 94 | detection of bacterium (GO:0016045) | 3.24110015 |
| 95 | homocysteine metabolic process (GO:0050667) | 3.23568939 |
| 96 | aspartate family amino acid catabolic process (GO:0009068) | 3.22614532 |
| 97 | drug catabolic process (GO:0042737) | 3.21568838 |
| 98 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.21279097 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.21255657 |
| 100 | coenzyme catabolic process (GO:0009109) | 3.20397153 |
| 101 | detection of other organism (GO:0098543) | 3.19376677 |
| 102 | defense response to protozoan (GO:0042832) | 3.19319213 |
| 103 | negative regulation of phagocytosis (GO:0050765) | 3.18465943 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16478784 |
| 105 | tolerance induction (GO:0002507) | 3.16208022 |
| 106 | reverse cholesterol transport (GO:0043691) | 3.16069255 |
| 107 | germinal center formation (GO:0002467) | 3.14556074 |
| 108 | regulation of leukocyte degranulation (GO:0043300) | 3.13336922 |
| 109 | regulation of B cell differentiation (GO:0045577) | 3.13314045 |
| 110 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10000099 |
| 111 | response to host immune response (GO:0052572) | 3.10000099 |
| 112 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.08909909 |
| 113 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.08828217 |
| 114 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08271563 |
| 115 | heme transport (GO:0015886) | 3.07986061 |
| 116 | regulation of ARF GTPase activity (GO:0032312) | 3.06317129 |
| 117 | positive regulation of mast cell activation (GO:0033005) | 3.06185518 |
| 118 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.04696630 |
| 119 | complement activation, alternative pathway (GO:0006957) | 3.00669239 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.00661575 |
| 121 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98830171 |
| 122 | protein-lipid complex remodeling (GO:0034368) | 2.98343205 |
| 123 | macromolecular complex remodeling (GO:0034367) | 2.98343205 |
| 124 | plasma lipoprotein particle remodeling (GO:0034369) | 2.98343205 |
| 125 | ethanol oxidation (GO:0006069) | 2.98311817 |
| 126 | regulation of complement activation (GO:0030449) | 2.98068884 |
| 127 | response to host (GO:0075136) | 2.96521058 |
| 128 | response to host defenses (GO:0052200) | 2.96521058 |
| 129 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96521058 |
| 130 | negative regulation of innate immune response (GO:0045824) | 2.95549900 |
| 131 | arginine metabolic process (GO:0006525) | 2.94054907 |
| 132 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92977347 |
| 133 | triglyceride homeostasis (GO:0070328) | 2.92120987 |
| 134 | acylglycerol homeostasis (GO:0055090) | 2.92120987 |
| 135 | regulation of cholesterol esterification (GO:0010872) | 2.91594572 |
| 136 | response to protozoan (GO:0001562) | 2.90501978 |
| 137 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.89926883 |
| 138 | positive thymic T cell selection (GO:0045059) | 2.89668535 |
| 139 | T cell migration (GO:0072678) | 2.88802925 |
| 140 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88425197 |
| 141 | protein carboxylation (GO:0018214) | 2.88425197 |
| 142 | myeloid cell activation involved in immune response (GO:0002275) | 2.88315794 |
| 143 | imidazole-containing compound metabolic process (GO:0052803) | 2.88267290 |
| 144 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88253279 |
| 145 | neutrophil activation involved in immune response (GO:0002283) | 2.87688107 |
| 146 | positive regulation of Rap GTPase activity (GO:0032854) | 2.87486385 |
| 147 | regulation of cholesterol homeostasis (GO:2000188) | 2.86431538 |
| 148 | macrophage activation (GO:0042116) | 2.86213253 |
| 149 | response to interleukin-15 (GO:0070672) | 2.86010591 |
| 150 | positive regulation of mast cell degranulation (GO:0043306) | 2.85407579 |
| 151 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.85407579 |
| 152 | negative regulation of granulocyte differentiation (GO:0030853) | 2.84691577 |
| 153 | folic acid metabolic process (GO:0046655) | 2.83400481 |
| 154 | plasma lipoprotein particle organization (GO:0071827) | 2.82957844 |
| 155 | positive regulation of protein deacetylation (GO:0090312) | 2.81840761 |
| 156 | natural killer cell differentiation (GO:0001779) | 2.80638560 |
| 157 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.79263586 |
| 158 | plasma lipoprotein particle clearance (GO:0034381) | 2.79071556 |
| 159 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.78883718 |
| 160 | one-carbon metabolic process (GO:0006730) | 2.77307620 |
| 161 | modulation by virus of host process (GO:0019054) | 2.76326387 |
| 162 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76321543 |
| 163 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.75938323 |
| 164 | Peyers patch development (GO:0048541) | 2.75938323 |
| 165 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.74943375 |
| 166 | microglial cell activation (GO:0001774) | 2.74187427 |
| 167 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.71356681 |
| 168 | carboxylic acid catabolic process (GO:0046395) | 2.70901170 |
| 169 | organic acid catabolic process (GO:0016054) | 2.70901170 |
| 170 | 4-hydroxyproline metabolic process (GO:0019471) | 2.70554435 |
| 171 | regulation of ARF protein signal transduction (GO:0032012) | 2.70003912 |
| 172 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.69533539 |
| 173 | regulation of regulated secretory pathway (GO:1903305) | 2.69204623 |
| 174 | tooth mineralization (GO:0034505) | 2.69168686 |
| 175 | immunoglobulin mediated immune response (GO:0016064) | 2.67732807 |
| 176 | B cell homeostasis (GO:0001782) | 2.67388837 |
| 177 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.64573543 |
| 178 | regulation of triglyceride catabolic process (GO:0010896) | 2.63787215 |
| 179 | protein-lipid complex subunit organization (GO:0071825) | 2.63739885 |
| 180 | regulation of mast cell activation (GO:0033003) | 2.62132807 |
| 181 | N-acetylneuraminate metabolic process (GO:0006054) | 2.61345476 |
| 182 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.59952610 |
| 183 | negative regulation of interleukin-6 production (GO:0032715) | 2.59834589 |
| 184 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59588723 |
| 185 | activated T cell proliferation (GO:0050798) | 2.59285585 |
| 186 | chaperone-mediated protein complex assembly (GO:0051131) | 2.58981375 |
| 187 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58304067 |
| 188 | ethanol metabolic process (GO:0006067) | 2.58028226 |
| 189 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.58023058 |
| 190 | negative regulation of type 2 immune response (GO:0002829) | 2.56346703 |
| 191 | histone H3-K36 demethylation (GO:0070544) | 2.55725180 |
| 192 | respiratory burst (GO:0045730) | 2.55639472 |
| 193 | response to type I interferon (GO:0034340) | 2.54049607 |
| 194 | detection of external biotic stimulus (GO:0098581) | 2.53443364 |
| 195 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52830651 |
| 196 | modulation by symbiont of host cellular process (GO:0044068) | 2.52245087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.16080028 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.71193154 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.11429514 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.77698056 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44952362 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.21232482 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 3.07880946 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97856293 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.78571290 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.67597714 |
| 11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.53793382 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.49716801 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.49511596 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.47748468 |
| 15 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.42046736 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38167424 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33061774 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.27013767 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.26431859 |
| 20 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.23588557 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16035955 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08409739 |
| 23 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06310846 |
| 24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04336257 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.03943166 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 2.02025381 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99892281 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97377993 |
| 29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.93495799 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.89908761 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87356055 |
| 32 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.76319663 |
| 33 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.75972934 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75280537 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74101286 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73804266 |
| 37 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.69452571 |
| 38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.69093800 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68849055 |
| 40 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.68062687 |
| 41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.67616711 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.67253534 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66745021 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.66358562 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65964744 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60023045 |
| 47 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57532720 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56416443 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55505025 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55266759 |
| 51 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53062468 |
| 52 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51264037 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50499503 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50496626 |
| 55 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48690607 |
| 56 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.48115597 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46118404 |
| 58 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.45376808 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42648856 |
| 60 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42373880 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42328172 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41288375 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40437131 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39831618 |
| 65 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.37590680 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.36779812 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.36411051 |
| 68 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36386911 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36244789 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.34098086 |
| 71 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.32121909 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31927691 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31449170 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30843846 |
| 75 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30823876 |
| 76 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.28318045 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28149092 |
| 78 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27923451 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.27472962 |
| 80 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.27079726 |
| 81 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26741608 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26036741 |
| 83 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.25133685 |
| 84 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.24981723 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23920114 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23207336 |
| 87 | * MYC_22102868_ChIP-Seq_BL_Human | 1.21927103 |
| 88 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21702469 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21127372 |
| 90 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20857411 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.20770617 |
| 92 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19950288 |
| 93 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19602951 |
| 94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19357477 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18974211 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18886963 |
| 97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.18532444 |
| 98 | MYB_26560356_Chip-Seq_TH1_Human | 1.17035099 |
| 99 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16586481 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16258183 |
| 101 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15786276 |
| 102 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.14737432 |
| 103 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.14639735 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14064673 |
| 105 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.13914937 |
| 106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.12996473 |
| 107 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12980211 |
| 108 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.11362291 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10518978 |
| 110 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10422518 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10352450 |
| 112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09949079 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09383354 |
| 114 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09032719 |
| 115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08010708 |
| 116 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.07680353 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07634390 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06810300 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 1.06500639 |
| 120 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06048791 |
| 121 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05748333 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05676189 |
| 123 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05345294 |
| 124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05110250 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05029377 |
| 126 | * MYB_26560356_Chip-Seq_TH2_Human | 1.04917620 |
| 127 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.04879639 |
| 128 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04408371 |
| 129 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04037191 |
| 130 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03944395 |
| 131 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03192491 |
| 132 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02583133 |
| 133 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02560981 |
| 134 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01874788 |
| 135 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01778330 |
| 136 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01231411 |
| 137 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01010969 |
| 138 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00827056 |
| 139 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.00031744 |
| 140 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00003280 |
| 141 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99513143 |
| 142 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96173047 |
| 143 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94849535 |
| 144 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.93815264 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93099075 |
| 146 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92815926 |
| 147 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.92549495 |
| 148 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.92429393 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92425922 |
| 150 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91759104 |
| 151 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91558399 |
| 152 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91412395 |
| 153 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.90223714 |
| 154 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89912795 |
| 155 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89206131 |
| 156 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.88602691 |
| 157 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86002851 |
| 158 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84927655 |
| 159 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84669505 |
| 160 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83581820 |
| 161 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83483594 |
| 162 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83336893 |
| 163 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83029740 |
| 164 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.82778167 |
| 165 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82702522 |
| 166 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82040544 |
| 167 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81813660 |
| 168 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.81186644 |
| 169 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80484224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.04470217 |
| 2 | MP0005360_urolithiasis | 5.21960952 |
| 3 | MP0005365_abnormal_bile_salt | 4.59601658 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.05678829 |
| 5 | MP0003436_decreased_susceptibility_to | 3.79801534 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.68726469 |
| 7 | MP0003011_delayed_dark_adaptation | 3.19931497 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.03687001 |
| 9 | MP0009278_abnormal_bone_marrow | 3.00997408 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.90574437 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.88096495 |
| 12 | MP0001800_abnormal_humoral_immune | 2.76805774 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.74395065 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.72119814 |
| 15 | MP0000685_abnormal_immune_system | 2.71256347 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.63585406 |
| 17 | MP0005387_immune_system_phenotype | 2.49719291 |
| 18 | MP0001790_abnormal_immune_system | 2.49719291 |
| 19 | MP0002419_abnormal_innate_immunity | 2.48119536 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.47327115 |
| 21 | MP0005025_abnormal_response_to | 2.46488125 |
| 22 | MP0002163_abnormal_gland_morphology | 2.46201280 |
| 23 | MP0005671_abnormal_response_to | 2.43608122 |
| 24 | MP0003252_abnormal_bile_duct | 2.38916111 |
| 25 | MP0002723_abnormal_immune_serum | 2.38025834 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.34923693 |
| 27 | MP0005332_abnormal_amino_acid | 2.33562318 |
| 28 | MP0001819_abnormal_immune_cell | 2.32902502 |
| 29 | MP0009840_abnormal_foam_cell | 2.28428259 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.23198449 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 2.17992163 |
| 32 | MP0001873_stomach_inflammation | 2.17617753 |
| 33 | MP0005083_abnormal_biliary_tract | 2.17057371 |
| 34 | MP0003329_amyloid_beta_deposits | 2.05546947 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 2.04923825 |
| 36 | MP0001849_ear_inflammation | 1.91881583 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.91701222 |
| 38 | MP0002405_respiratory_system_inflammati | 1.90562250 |
| 39 | MP0005187_abnormal_penis_morphology | 1.88275135 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.87063635 |
| 41 | MP0002254_reproductive_system_inflammat | 1.85749023 |
| 42 | MP0000716_abnormal_immune_system | 1.84164950 |
| 43 | MP0008260_abnormal_autophagy | 1.82942422 |
| 44 | MP0002398_abnormal_bone_marrow | 1.82427244 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.82022357 |
| 46 | MP0004270_analgesia | 1.80531172 |
| 47 | MP0003724_increased_susceptibility_to | 1.76651789 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.73045230 |
| 49 | MP0001348_abnormal_lacrimal_gland | 1.69377701 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.68687390 |
| 51 | MP0000609_abnormal_liver_physiology | 1.68573861 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.67773747 |
| 53 | MP0009785_altered_susceptibility_to | 1.66735216 |
| 54 | MP0005310_abnormal_salivary_gland | 1.66663703 |
| 55 | MP0006082_CNS_inflammation | 1.65805887 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.61931196 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.60776969 |
| 58 | MP0004947_skin_inflammation | 1.60762162 |
| 59 | MP0003195_calcinosis | 1.59529960 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 1.55488136 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.55036598 |
| 62 | MP0004381_abnormal_hair_follicle | 1.53430320 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.50659621 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.48995345 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.48007387 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.46159191 |
| 67 | MP0004019_abnormal_vitamin_homeostasis | 1.45966435 |
| 68 | MP0002429_abnormal_blood_cell | 1.45702034 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.44439802 |
| 70 | MP0002722_abnormal_immune_system | 1.42574366 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.39582847 |
| 72 | MP0001545_abnormal_hematopoietic_system | 1.34740557 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.34740557 |
| 74 | MP0006276_abnormal_autonomic_nervous | 1.32136682 |
| 75 | MP0001663_abnormal_digestive_system | 1.29418108 |
| 76 | MP0008877_abnormal_DNA_methylation | 1.28076642 |
| 77 | MP0003283_abnormal_digestive_organ | 1.27195727 |
| 78 | MP0002933_joint_inflammation | 1.26797709 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 1.25330590 |
| 80 | MP0003866_abnormal_defecation | 1.22957890 |
| 81 | MP0001270_distended_abdomen | 1.22735710 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.22168699 |
| 83 | MP0005451_abnormal_body_composition | 1.17493801 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.17214810 |
| 85 | MP0003136_yellow_coat_color | 1.16635632 |
| 86 | MP0000678_abnormal_parathyroid_gland | 1.15912219 |
| 87 | MP0000858_altered_metastatic_potential | 1.14649612 |
| 88 | MP0004858_abnormal_nervous_system | 1.13544901 |
| 89 | MP0008469_abnormal_protein_level | 1.12605214 |
| 90 | MP0000604_amyloidosis | 1.11422716 |
| 91 | MP0006292_abnormal_olfactory_placode | 1.09002695 |
| 92 | MP0009672_abnormal_birth_weight | 1.06164049 |
| 93 | MP0002249_abnormal_larynx_morphology | 1.04561778 |
| 94 | MP0004130_abnormal_muscle_cell | 1.02891758 |
| 95 | MP0002064_seizures | 1.02181991 |
| 96 | MP0004811_abnormal_neuron_physiology | 1.01104533 |
| 97 | MP0005670_abnormal_white_adipose | 1.00749336 |
| 98 | MP0004885_abnormal_endolymph | 1.00489631 |
| 99 | MP0003119_abnormal_digestive_system | 0.99820577 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.99076349 |
| 101 | MP0002160_abnormal_reproductive_system | 0.98812910 |
| 102 | MP0004043_abnormal_pH_regulation | 0.98778499 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.98579815 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.97868534 |
| 105 | MP0004510_myositis | 0.96234870 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96110030 |
| 107 | MP0003635_abnormal_synaptic_transmissio | 0.95836438 |
| 108 | MP0000470_abnormal_stomach_morphology | 0.95000644 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.94596225 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 0.94453696 |
| 111 | MP0002734_abnormal_mechanical_nocicepti | 0.93114468 |
| 112 | MP0003303_peritoneal_inflammation | 0.92499442 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.92097752 |
| 114 | MP0001944_abnormal_pancreas_morphology | 0.91377078 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.90624078 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.90422876 |
| 117 | MP0004808_abnormal_hematopoietic_stem | 0.90285251 |
| 118 | MP0000537_abnormal_urethra_morphology | 0.90172960 |
| 119 | MP0002009_preneoplasia | 0.89673974 |
| 120 | MP0003868_abnormal_feces_composition | 0.89078486 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.88526498 |
| 122 | MP0000955_abnormal_spinal_cord | 0.86960063 |
| 123 | MP0005410_abnormal_fertilization | 0.86952053 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.86796520 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.84820775 |
| 126 | MP0004883_abnormal_blood_vessel | 0.84532717 |
| 127 | MP0002078_abnormal_glucose_homeostasis | 0.84211642 |
| 128 | MP0005319_abnormal_enzyme/_coenzyme | 0.84087971 |
| 129 | MP0000490_abnormal_crypts_of | 0.83077830 |
| 130 | MP0002098_abnormal_vibrissa_morphology | 0.82970550 |
| 131 | MP0002184_abnormal_innervation | 0.81775872 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.80948906 |
| 133 | MP0000358_abnormal_cell_content/ | 0.80482795 |
| 134 | MP0003787_abnormal_imprinting | 0.79888893 |
| 135 | MP0002277_abnormal_respiratory_mucosa | 0.79708745 |
| 136 | MP0003828_pulmonary_edema | 0.77980316 |
| 137 | MP0003123_paternal_imprinting | 0.77928830 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.77028250 |
| 139 | MP0000598_abnormal_liver_morphology | 0.75624417 |
| 140 | MP0002063_abnormal_learning/memory/cond | 0.75029483 |
| 141 | MP0005390_skeleton_phenotype | 0.74875179 |
| 142 | MP0001502_abnormal_circadian_rhythm | 0.74551168 |
| 143 | MP0009764_decreased_sensitivity_to | 0.74131615 |
| 144 | MP0004133_heterotaxia | 0.73603729 |
| 145 | MP0003861_abnormal_nervous_system | 0.73325928 |
| 146 | MP0002132_abnormal_respiratory_system | 0.72931856 |
| 147 | MP0002928_abnormal_bile_duct | 0.71841594 |
| 148 | MP0005075_abnormal_melanosome_morpholog | 0.70789457 |
| 149 | MP0001851_eye_inflammation | 0.70743174 |
| 150 | MP0008789_abnormal_olfactory_epithelium | 0.70539843 |
| 151 | MP0003453_abnormal_keratinocyte_physiol | 0.69856366 |
| 152 | MP0003315_abnormal_perineum_morphology | 0.69429544 |
| 153 | MP0005394_taste/olfaction_phenotype | 0.69175272 |
| 154 | MP0005499_abnormal_olfactory_system | 0.69175272 |
| 155 | MP0000538_abnormal_urinary_bladder | 0.68594694 |
| 156 | MP0009053_abnormal_anal_canal | 0.68530625 |
| 157 | MP0000778_abnormal_nervous_system | 0.67698403 |
| 158 | MP0002653_abnormal_ependyma_morphology | 0.66241570 |
| 159 | MP0003879_abnormal_hair_cell | 0.66089405 |
| 160 | MP0001730_embryonic_growth_arrest | 0.65740330 |
| 161 | MP0003690_abnormal_glial_cell | 0.65199806 |
| 162 | MP0003300_gastrointestinal_ulcer | 0.64899147 |
| 163 | MP0005375_adipose_tissue_phenotype | 0.64597057 |
| 164 | MP0009379_abnormal_foot_pigmentation | 0.64441429 |
| 165 | MP0001968_abnormal_touch/_nociception | 0.64411098 |
| 166 | MP0000371_diluted_coat_color | 0.63972364 |
| 167 | MP0002796_impaired_skin_barrier | 0.63520517 |
| 168 | MP0001970_abnormal_pain_threshold | 0.63324734 |
| 169 | MP0002152_abnormal_brain_morphology | 0.62399835 |
| 170 | MP0000750_abnormal_muscle_regeneration | 0.61980264 |
| 171 | MP0003698_abnormal_male_reproductive | 0.61761607 |
| 172 | MP0001853_heart_inflammation | 0.61706695 |
| 173 | MP0001765_abnormal_ion_homeostasis | 0.61081969 |
| 174 | MP0005409_darkened_coat_color | 0.60343047 |
| 175 | MP0003656_abnormal_erythrocyte_physiolo | 0.60160354 |
| 176 | MP0005076_abnormal_cell_differentiation | 0.57866058 |
| 177 | MP0005647_abnormal_sex_gland | 0.57743961 |
| 178 | MP0005448_abnormal_energy_balance | 0.57458106 |
| 179 | MP0003878_abnormal_ear_physiology | 0.57317320 |
| 180 | MP0005377_hearing/vestibular/ear_phenot | 0.57317320 |
| 181 | MP0008874_decreased_physiological_sensi | 0.57116373 |
| 182 | MP0002572_abnormal_emotion/affect_behav | 0.56609612 |
| 183 | MP0001727_abnormal_embryo_implantation | 0.56537443 |
| 184 | MP0002751_abnormal_autonomic_nervous | 0.56257749 |
| 185 | MP0003075_altered_response_to | 0.55656454 |
| 186 | MP0000681_abnormal_thyroid_gland | 0.55585102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.57935323 |
| 2 | Autoimmune hemolytic anemia (HP:0001890) | 5.15549058 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.88274214 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.78454748 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.65668536 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.54029232 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.35720810 |
| 8 | Xanthomatosis (HP:0000991) | 4.19236523 |
| 9 | Abnormal pupillary function (HP:0007686) | 4.02352924 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.94872810 |
| 11 | Abnormality of the Achilles tendon (HP:0005109) | 3.70751775 |
| 12 | Ketosis (HP:0001946) | 3.70064936 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.67933307 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.64812980 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.62381388 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.57277764 |
| 17 | Obstructive lung disease (HP:0006536) | 3.57277764 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.50373990 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.49614205 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.47232458 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.45801851 |
| 22 | Microretrognathia (HP:0000308) | 3.44100621 |
| 23 | Myositis (HP:0100614) | 3.41994788 |
| 24 | Hyperglycinemia (HP:0002154) | 3.38760923 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.36665127 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 3.36509590 |
| 27 | Achilles tendon contracture (HP:0001771) | 3.35546681 |
| 28 | Hypochromic anemia (HP:0001931) | 3.32241490 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31567769 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31567769 |
| 31 | Cortical dysplasia (HP:0002539) | 3.30157774 |
| 32 | Large eyes (HP:0001090) | 3.22740722 |
| 33 | Colitis (HP:0002583) | 3.21648950 |
| 34 | Meningitis (HP:0001287) | 3.19734223 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17861575 |
| 36 | Broad distal phalanx of finger (HP:0009836) | 3.16046797 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.14796702 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.14796702 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 3.09769826 |
| 40 | Hyperammonemia (HP:0001987) | 3.08557391 |
| 41 | Hyperglycinuria (HP:0003108) | 3.07106958 |
| 42 | Abnormality of the lower motor neuron (HP:0002366) | 3.04313671 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.00290594 |
| 44 | Orchitis (HP:0100796) | 2.99851799 |
| 45 | Hyperlipoproteinemia (HP:0010980) | 2.99723603 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.94457492 |
| 47 | Gout (HP:0001997) | 2.92919196 |
| 48 | Ketoacidosis (HP:0001993) | 2.91862651 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.90662503 |
| 50 | Stomatitis (HP:0010280) | 2.87992542 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.86067159 |
| 52 | Obstructive sleep apnea (HP:0002870) | 2.84420508 |
| 53 | Cellulitis (HP:0100658) | 2.81334033 |
| 54 | Pustule (HP:0200039) | 2.79537133 |
| 55 | Recurrent skin infections (HP:0001581) | 2.78796660 |
| 56 | Areflexia of lower limbs (HP:0002522) | 2.78397378 |
| 57 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76436091 |
| 58 | Optic neuritis (HP:0100653) | 2.73876020 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.73876020 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.64611853 |
| 61 | Thoracic kyphosis (HP:0002942) | 2.64491462 |
| 62 | Fat malabsorption (HP:0002630) | 2.62846381 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.62307696 |
| 64 | Encephalitis (HP:0002383) | 2.61230474 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60629088 |
| 66 | Epidermoid cyst (HP:0200040) | 2.59641955 |
| 67 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55196135 |
| 68 | Myokymia (HP:0002411) | 2.50950689 |
| 69 | Atrioventricular block (HP:0001678) | 2.50903219 |
| 70 | Vasculitis (HP:0002633) | 2.50820806 |
| 71 | Recurrent viral infections (HP:0004429) | 2.49335354 |
| 72 | Abnormality of the fingertips (HP:0001211) | 2.48584677 |
| 73 | Abnormality of the thoracic spine (HP:0100711) | 2.47786169 |
| 74 | Hyperacusis (HP:0010780) | 2.45777411 |
| 75 | Increased IgE level (HP:0003212) | 2.45511352 |
| 76 | Gingivitis (HP:0000230) | 2.43926088 |
| 77 | Complement deficiency (HP:0004431) | 2.40119922 |
| 78 | Thin bony cortex (HP:0002753) | 2.39070588 |
| 79 | Congenital glaucoma (HP:0001087) | 2.37596193 |
| 80 | Hypoglycemic coma (HP:0001325) | 2.35895810 |
| 81 | Concave nail (HP:0001598) | 2.34630325 |
| 82 | Hypoalphalipoproteinemia (HP:0003233) | 2.33689893 |
| 83 | Hemoptysis (HP:0002105) | 2.32479836 |
| 84 | Deep palmar crease (HP:0006191) | 2.31335207 |
| 85 | Delayed CNS myelination (HP:0002188) | 2.31044580 |
| 86 | Chest pain (HP:0100749) | 2.29728595 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 2.29323244 |
| 88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.28809027 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.28619469 |
| 90 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28469386 |
| 91 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28469386 |
| 92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28469386 |
| 93 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28339895 |
| 94 | Cerebral edema (HP:0002181) | 2.25448919 |
| 95 | Lymphopenia (HP:0001888) | 2.21570628 |
| 96 | Annular pancreas (HP:0001734) | 2.21266738 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.20133000 |
| 98 | Late onset (HP:0003584) | 2.19012568 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16038580 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16038580 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16038580 |
| 102 | Neonatal onset (HP:0003623) | 2.15943505 |
| 103 | Tetraplegia (HP:0002445) | 2.14654529 |
| 104 | Abnormality of methionine metabolism (HP:0010901) | 2.13745418 |
| 105 | Hand muscle atrophy (HP:0009130) | 2.12412927 |
| 106 | Spastic diplegia (HP:0001264) | 2.12302684 |
| 107 | Increased serum ferritin (HP:0003281) | 2.11974943 |
| 108 | Testicular neoplasm (HP:0010788) | 2.10103591 |
| 109 | Abnormality of serum amino acid levels (HP:0003112) | 2.09805709 |
| 110 | Global brain atrophy (HP:0002283) | 2.09340180 |
| 111 | Gastrointestinal stroma tumor (HP:0100723) | 2.09220997 |
| 112 | Spontaneous hematomas (HP:0007420) | 2.08610546 |
| 113 | Irritability (HP:0000737) | 2.07956008 |
| 114 | Status epilepticus (HP:0002133) | 2.07854817 |
| 115 | Broad face (HP:0000283) | 2.07706813 |
| 116 | Hyperbilirubinemia (HP:0002904) | 2.06274063 |
| 117 | Supranuclear gaze palsy (HP:0000605) | 2.03568508 |
| 118 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01959001 |
| 119 | Torticollis (HP:0000473) | 1.99998904 |
| 120 | Cerebral aneurysm (HP:0004944) | 1.99961871 |
| 121 | Spinal canal stenosis (HP:0003416) | 1.99376338 |
| 122 | Cheilitis (HP:0100825) | 1.98893214 |
| 123 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98363809 |
| 124 | Hypertensive crisis (HP:0100735) | 1.97281650 |
| 125 | Malnutrition (HP:0004395) | 1.97144779 |
| 126 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97042658 |
| 127 | Focal dystonia (HP:0004373) | 1.96512009 |
| 128 | Conjugated hyperbilirubinemia (HP:0002908) | 1.96215384 |
| 129 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.96213312 |
| 130 | Craniofacial dystonia (HP:0012179) | 1.94178785 |
| 131 | Oligodontia (HP:0000677) | 1.93557546 |
| 132 | Amblyopia (HP:0000646) | 1.93414734 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.90700542 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90700542 |
| 135 | Lethargy (HP:0001254) | 1.90353059 |
| 136 | Loss of speech (HP:0002371) | 1.88076295 |
| 137 | Keratoconjunctivitis (HP:0001096) | 1.85764876 |
| 138 | Restrictive lung disease (HP:0002091) | 1.85653500 |
| 139 | Stridor (HP:0010307) | 1.85516581 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.85450457 |
| 141 | Keratoconjunctivitis sicca (HP:0001097) | 1.85149788 |
| 142 | Cerebral inclusion bodies (HP:0100314) | 1.84819724 |
| 143 | Pulmonary embolism (HP:0002204) | 1.84811064 |
| 144 | Hypoglycemic seizures (HP:0002173) | 1.84626553 |
| 145 | Distal upper limb amyotrophy (HP:0007149) | 1.84312342 |
| 146 | Upper limb amyotrophy (HP:0009129) | 1.84312342 |
| 147 | Delusions (HP:0000746) | 1.84266650 |
| 148 | Emphysema (HP:0002097) | 1.83333699 |
| 149 | Abnormality of nucleobase metabolism (HP:0010932) | 1.82829849 |
| 150 | Papilloma (HP:0012740) | 1.82717678 |
| 151 | Verrucae (HP:0200043) | 1.82717678 |
| 152 | Steatorrhea (HP:0002570) | 1.82032362 |
| 153 | J-shaped sella turcica (HP:0002680) | 1.81828586 |
| 154 | Episodic fever (HP:0001954) | 1.81721068 |
| 155 | Spontaneous abortion (HP:0005268) | 1.80227495 |
| 156 | Thrombocytosis (HP:0001894) | 1.80088700 |
| 157 | Back pain (HP:0003418) | 1.78939596 |
| 158 | Nasal polyposis (HP:0100582) | 1.78438650 |
| 159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.78146743 |
| 160 | Neuronal loss in central nervous system (HP:0002529) | 1.78037450 |
| 161 | Alveolar cell carcinoma (HP:0006519) | 1.76669022 |
| 162 | Urticaria (HP:0001025) | 1.76461228 |
| 163 | Supernumerary nipples (HP:0002558) | 1.75900319 |
| 164 | Epistaxis (HP:0000421) | 1.75473549 |
| 165 | Abnormality of the nasal mucosa (HP:0000433) | 1.74569876 |
| 166 | Abnormality of purine metabolism (HP:0004352) | 1.73265273 |
| 167 | Pseudobulbar signs (HP:0002200) | 1.73234871 |
| 168 | Abnormality of the pleura (HP:0002103) | 1.73173943 |
| 169 | Abnormality of the endocardium (HP:0004306) | 1.73009945 |
| 170 | Acrocyanosis (HP:0001063) | 1.72593241 |
| 171 | Poor suck (HP:0002033) | 1.71600237 |
| 172 | Hypercholesterolemia (HP:0003124) | 1.71379028 |
| 173 | Pheochromocytoma (HP:0002666) | 1.70827531 |
| 174 | Pointed chin (HP:0000307) | 1.70689916 |
| 175 | Abnormality of T cells (HP:0002843) | 1.70332368 |
| 176 | Polygenic inheritance (HP:0010982) | 1.69187355 |
| 177 | Granulocytopenia (HP:0001913) | 1.68950402 |
| 178 | Abnormal tarsal ossification (HP:0008369) | 1.68859059 |
| 179 | Abnormality of the aortic arch (HP:0012303) | 1.68654233 |
| 180 | Abnormality of the intrinsic pathway (HP:0010989) | 1.68603392 |
| 181 | Easy fatigability (HP:0003388) | 1.68603040 |
| 182 | Delayed myelination (HP:0012448) | 1.67638628 |
| 183 | Visual hallucinations (HP:0002367) | 1.66829253 |
| 184 | Restlessness (HP:0000711) | 1.66665614 |
| 185 | Rectal prolapse (HP:0002035) | 1.66383851 |
| 186 | Death in childhood (HP:0003819) | 1.66217416 |
| 187 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.63099807 |
| 188 | Impaired pain sensation (HP:0007328) | 1.61252760 |
| 189 | Abnormality of pain sensation (HP:0010832) | 1.61252760 |
| 190 | Patent foramen ovale (HP:0001655) | 1.61117120 |
| 191 | Polycythemia (HP:0001901) | 1.60856656 |
| 192 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.60824097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRD4 | 5.00540464 |
| 2 | RIPK1 | 4.10025077 |
| 3 | EEF2K | 4.03922791 |
| 4 | MAP4K1 | 3.55076973 |
| 5 | DAPK2 | 3.00241176 |
| 6 | DYRK3 | 2.78335487 |
| 7 | BCKDK | 2.55758745 |
| 8 | PRPF4B | 2.54558081 |
| 9 | MARK1 | 2.41919289 |
| 10 | MAP3K13 | 2.37548011 |
| 11 | TNK2 | 2.33087239 |
| 12 | DYRK2 | 2.32568698 |
| 13 | MAPKAPK3 | 2.32465299 |
| 14 | MAP2K3 | 2.27791066 |
| 15 | MAP3K4 | 2.21187819 |
| 16 | BCR | 2.18301460 |
| 17 | RIPK4 | 2.18107383 |
| 18 | MAP3K10 | 2.16096064 |
| 19 | MAP3K9 | 2.14419143 |
| 20 | MAP3K2 | 2.11740270 |
| 21 | DYRK1B | 2.05319201 |
| 22 | IRAK4 | 1.87418908 |
| 23 | MARK2 | 1.74009327 |
| 24 | PRKD3 | 1.72598326 |
| 25 | BTK | 1.67380069 |
| 26 | IRAK3 | 1.63775923 |
| 27 | TYK2 | 1.63599846 |
| 28 | LATS2 | 1.61002107 |
| 29 | SMG1 | 1.60586524 |
| 30 | FER | 1.58389291 |
| 31 | BLK | 1.57652666 |
| 32 | MAP2K4 | 1.57180985 |
| 33 | CAMKK1 | 1.56998161 |
| 34 | MAP3K7 | 1.50923655 |
| 35 | PRKD2 | 1.46896322 |
| 36 | CDK4 | 1.44389358 |
| 37 | MAPK15 | 1.41875930 |
| 38 | AURKA | 1.39880202 |
| 39 | NEK2 | 1.39793801 |
| 40 | FES | 1.34936599 |
| 41 | CDK12 | 1.34907664 |
| 42 | CSK | 1.32485939 |
| 43 | MINK1 | 1.31325495 |
| 44 | ZAP70 | 1.30601925 |
| 45 | ICK | 1.28928442 |
| 46 | PAK3 | 1.28377946 |
| 47 | JAK3 | 1.27687715 |
| 48 | ITK | 1.27663601 |
| 49 | IKBKE | 1.26129524 |
| 50 | WNK3 | 1.24152184 |
| 51 | KSR2 | 1.22653883 |
| 52 | RPS6KB1 | 1.20686605 |
| 53 | BUB1 | 1.19615927 |
| 54 | CDC42BPA | 1.18009889 |
| 55 | UHMK1 | 1.18002342 |
| 56 | EPHA2 | 1.17765807 |
| 57 | TBK1 | 1.17268589 |
| 58 | FGFR4 | 1.15682947 |
| 59 | TESK1 | 1.14555182 |
| 60 | SYK | 1.13746491 |
| 61 | CAMK1D | 1.11589840 |
| 62 | MAP3K14 | 1.10086289 |
| 63 | RPS6KC1 | 1.09913337 |
| 64 | RPS6KL1 | 1.09913337 |
| 65 | SIK1 | 1.06773738 |
| 66 | TAOK1 | 1.04839873 |
| 67 | CSF1R | 1.03913910 |
| 68 | RPS6KA6 | 1.03707160 |
| 69 | IRAK2 | 1.02570678 |
| 70 | MAP2K6 | 1.01948163 |
| 71 | PDK1 | 1.00417497 |
| 72 | ARAF | 1.00213644 |
| 73 | PASK | 0.98913687 |
| 74 | TRIB3 | 0.98809670 |
| 75 | IKBKB | 0.97998437 |
| 76 | PAK6 | 0.97488636 |
| 77 | HCK | 0.95503259 |
| 78 | CAMK2G | 0.95401226 |
| 79 | PDPK1 | 0.94973620 |
| 80 | MAP3K11 | 0.94721085 |
| 81 | NTRK2 | 0.94287032 |
| 82 | LCK | 0.90307582 |
| 83 | CAMK2D | 0.90126688 |
| 84 | PRKCI | 0.89293298 |
| 85 | MAP3K1 | 0.86963754 |
| 86 | KIT | 0.86899819 |
| 87 | LRRK2 | 0.86009145 |
| 88 | RPS6KA2 | 0.84193877 |
| 89 | FGR | 0.82805834 |
| 90 | PDK3 | 0.82626617 |
| 91 | PDK4 | 0.82626617 |
| 92 | TYRO3 | 0.82371141 |
| 93 | BMX | 0.81197175 |
| 94 | TXK | 0.80983453 |
| 95 | MAPK12 | 0.80420750 |
| 96 | MAP3K3 | 0.80353627 |
| 97 | RPS6KB2 | 0.79772289 |
| 98 | LYN | 0.79396162 |
| 99 | BRAF | 0.79075432 |
| 100 | CAMKK2 | 0.78700724 |
| 101 | MAP2K7 | 0.77588996 |
| 102 | STK16 | 0.77086762 |
| 103 | PRKCZ | 0.74499400 |
| 104 | KSR1 | 0.74435895 |
| 105 | ERBB4 | 0.72642664 |
| 106 | SIK2 | 0.72427230 |
| 107 | CDK11A | 0.71575702 |
| 108 | CSNK1G2 | 0.70991051 |
| 109 | MAPK11 | 0.70906043 |
| 110 | MAP3K6 | 0.69318000 |
| 111 | NME2 | 0.69058079 |
| 112 | GSK3A | 0.68885334 |
| 113 | TESK2 | 0.67720243 |
| 114 | CSNK1G3 | 0.66685873 |
| 115 | MATK | 0.66518380 |
| 116 | ACVR1B | 0.66205286 |
| 117 | EPHA4 | 0.65553143 |
| 118 | MAPK13 | 0.65276648 |
| 119 | PNCK | 0.65015353 |
| 120 | PTK2 | 0.63829210 |
| 121 | CDK6 | 0.63025897 |
| 122 | ERN1 | 0.62756387 |
| 123 | CDK5 | 0.62347434 |
| 124 | FGFR3 | 0.61663935 |
| 125 | MAP2K2 | 0.61629991 |
| 126 | NTRK1 | 0.60568703 |
| 127 | MTOR | 0.59986965 |
| 128 | PRKCH | 0.59407523 |
| 129 | CDK19 | 0.59239700 |
| 130 | PHKG1 | 0.58539051 |
| 131 | PHKG2 | 0.58539051 |
| 132 | CHUK | 0.57202181 |
| 133 | DYRK1A | 0.56954871 |
| 134 | CAMK1G | 0.55929135 |
| 135 | TTN | 0.55392284 |
| 136 | CAMK1 | 0.55353171 |
| 137 | STK11 | 0.54473395 |
| 138 | AURKB | 0.54128022 |
| 139 | PRKCQ | 0.53944536 |
| 140 | WNK4 | 0.53923949 |
| 141 | CDK14 | 0.53793007 |
| 142 | TAOK2 | 0.53773326 |
| 143 | NEK1 | 0.53449076 |
| 144 | CDK15 | 0.52953296 |
| 145 | CAMK4 | 0.52363248 |
| 146 | ABL2 | 0.51852644 |
| 147 | MARK3 | 0.51717055 |
| 148 | EPHB1 | 0.51623444 |
| 149 | SGK3 | 0.51437427 |
| 150 | SCYL2 | 0.51254272 |
| 151 | FGFR2 | 0.50160699 |
| 152 | CDK18 | 0.48902180 |
| 153 | KDR | 0.45779945 |
| 154 | GRK6 | 0.45298092 |
| 155 | PRKAA1 | 0.44551867 |
| 156 | MAPK7 | 0.43681845 |
| 157 | LMTK2 | 0.42886724 |
| 158 | TEC | 0.41752162 |
| 159 | MAPKAPK5 | 0.41563966 |
| 160 | PIM1 | 0.41436249 |
| 161 | CSNK1G1 | 0.41142651 |
| 162 | FYN | 0.39629136 |
| 163 | IRAK1 | 0.39610463 |
| 164 | SGK223 | 0.39117796 |
| 165 | SGK494 | 0.39117796 |
| 166 | PKN2 | 0.37371322 |
| 167 | NTRK3 | 0.35416341 |
| 168 | LIMK1 | 0.34504386 |
| 169 | ALK | 0.34126612 |
| 170 | RPS6KA1 | 0.33124050 |
| 171 | HIPK2 | 0.31912897 |
| 172 | AKT2 | 0.31480473 |
| 173 | PTK6 | 0.30938041 |
| 174 | PRKCG | 0.30247185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45853889 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.29245288 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.16350615 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86279188 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.85523024 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69997230 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62976459 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.57871205 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.47451775 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.46268355 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36300132 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35737133 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.34205296 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.31507921 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.28987891 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.20265609 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17965237 |
| 18 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.15402520 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14411938 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12893307 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.09572267 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.07783376 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.05314586 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88318217 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87549267 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.86093722 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84271239 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83516292 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77829212 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76163772 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75897545 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73821238 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.73607061 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72161530 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69305327 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64842291 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62022458 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.61756550 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59343780 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.57449867 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.56753535 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53291611 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47963081 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47797313 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.46017199 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44930165 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43615900 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43374470 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42796840 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40908746 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.40104637 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37875483 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.37607046 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37516916 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37087632 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34697240 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34290307 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33267688 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.32508189 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32113346 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31350885 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29684439 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27933403 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27321151 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 1.25845577 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24073719 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23472848 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23388945 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22558886 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20946430 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19827696 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19615459 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19556006 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18998920 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18581836 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.18126807 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.17708108 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.16607310 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14491156 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13727999 |
| 81 | Measles_Homo sapiens_hsa05162 | 1.13163038 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 1.12806063 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08996742 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 1.08722697 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.06148735 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06067374 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05872737 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 1.05376671 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05152443 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01190088 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.98603941 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98324595 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97960776 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95688803 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95469307 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94591957 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91384325 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.90992712 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.90456386 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88822386 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.88799980 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88011422 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87732638 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87338456 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87197738 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86738827 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85440631 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.84810339 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83883789 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83882480 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82597205 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.82469206 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81429461 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79585301 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79216865 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78519719 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77086925 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76575242 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76197490 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75428088 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74491253 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74226555 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72543219 |
| 124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72268008 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.70779929 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70631863 |
| 127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69950049 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69489117 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67107255 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67056907 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66422654 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65533620 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64250764 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.60613235 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60495036 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.60197922 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59721321 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59227025 |
| 139 | Lysine degradation_Homo sapiens_hsa00310 | 0.58668981 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.57981178 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57955309 |
| 142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55732707 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55394017 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54455381 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53124407 |
| 146 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52700149 |
| 147 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52054966 |
| 148 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51945938 |
| 149 | Alcoholism_Homo sapiens_hsa05034 | 0.51736190 |
| 150 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51584706 |
| 151 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51176247 |
| 152 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50303767 |
| 153 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50283320 |
| 154 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49531337 |
| 155 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49305838 |
| 156 | Phagosome_Homo sapiens_hsa04145 | 0.46534353 |
| 157 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46365663 |
| 158 | Pertussis_Homo sapiens_hsa05133 | 0.46246257 |
| 159 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44998385 |
| 160 | Insulin secretion_Homo sapiens_hsa04911 | 0.44115514 |
| 161 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43382119 |
| 162 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42851572 |
| 163 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40176105 |
| 164 | Insulin resistance_Homo sapiens_hsa04931 | 0.37815844 |
| 165 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37763671 |
| 166 | Prion diseases_Homo sapiens_hsa05020 | 0.36184232 |
| 167 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34733381 |
| 168 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33925283 |
| 169 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31624255 |
| 170 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31478983 |
| 171 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31311977 |
| 172 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31075399 |
| 173 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26983983 |
| 174 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26827402 |
| 175 | Parkinsons disease_Homo sapiens_hsa05012 | 0.21254508 |
| 176 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.20768729 |
| 177 | Gap junction_Homo sapiens_hsa04540 | 0.20657404 |
| 178 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18861802 |
| 179 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17326339 |
| 180 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17145766 |
| 181 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16938612 |
| 182 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.16156438 |
| 183 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.15318533 |
| 184 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.13729211 |
| 185 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.13052603 |
| 186 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.11533820 |
| 187 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.10378947 |

